Oncology Peer Review On-The-Go: Practical Considerations for Small Cell Lung Cancer Therapeutic Options
In episode 3 of a 4-part small cell lung cancer podcast series, Wade Iams, MD, highlights practical considerations for treating patients with small cell lung cancer, including managing toxicities and the impact of treatment on a patient’s quality of life.
In the third part of a 4-part series on small cell lung cancer (SCLC), CancerNetwork spoke with Wade Iams, MD, a thoracic medical oncologist at the Vanderbilt University Medical Center about the occurrence of toxicities associated with treatment, quality of life for patients, and managing and mitigating those events for individuals with SCLC. Some of the agents and regimens discussed include lurbinectedin (Zepzelca) and trilaciclib (Cosela), as well as chemotherapy and immunotherapy.
Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
Check out the previous podcast episodes in this series:
